Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?

Shares of Amylyx Pharmaceuticals, Inc. (AMLX) have gained 26.7% over the past four weeks to close the last trading session at $5.36, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11 indicates a potential upside of 105.2%.The average comprises five short-term price targets ranging from a low of $8 to a high of $16, with a standard deviation of $3. While the lowest estimate ind ...